Neoplastic Cell Activation And Proliferative Response To CD40-Ligand Characterize Recurrent Leukemic Bouts In An Unusual Case Of Low Grade Lymphoma

References

• Kaufmann Y., Many A., Rechavi G., Mor O., Biniaminov M., Rosenthal E., Levanon M., Davidsohn J., Aizman I., Mark Z., Brok-Simoni F, Ramot B. Lymphoma with recurrent cycles of spontaneous remission and relapse-possible role of apoptosis. N. Engl. J. Med. 1995; 332: 507–510
   PubMed Web of Science ®Google Scholar
• Homing S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med. 1984; 311: 1471–1475
   PubMed Web of Science ®Google Scholar
• Gattiker H. H., Wiltshaw E., Galton D. A. Spontaneous regression in non-Hodgkin's lymphoma. Cancer 1980; 45: 2627–2632
   PubMed Web of Science ®Google Scholar
• Papac R. J. Spontaneous regression of cancer. Cancer Treat. Rev. 1996; 22: 395–423
   PubMed Web of Science ®Google Scholar
• Nagel S., Borisch B., von Rohr A., Tobler A., Fey M. F. Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lym-phocytic leukemia. Ann. Oncol. 1996; 7: 953–960
   PubMed Web of Science ®Google Scholar
• Dolcetti R., De Re V., Carbone A., De Vita S., Gloghini A., Tirelli U., Pasquotti B., Boiocchi M. Geno-typic and immunohistological demonstration of the progression of an unusual reactive-like B-cell lymphoproliferative disorder to a high grade diffuse lymphoma. Hum. Pathol. 1995; 26: 348–354
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Follicular lymphomas: possibility that they are benign tumors of the lymphoid system. J. Natl. Cancer Inst. 1983; 70: 401–403, 1983
   PubMed Web of Science ®Google Scholar
• Krikorian J. G., Portlock C. S., Cooney P., Rosenberg S. A. Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer 1980; 46: 2093–2099
   PubMed Web of Science ®Google Scholar
• Montserrat E. Chronic lymphoproliferative disorders. Curr. Opin. Oncol. 1997; 9: 34–41
   PubMedGoogle Scholar
• Dolcetti R., Boiocchi M. Cellular and molecular bases of B-cell clonal expansions. Clin. Exp. Rheumatol. 1996; 14(Suppl. 14)S3–13
   PubMedGoogle Scholar
• Hsu S. M., Waldron J. W., Jr, Hsu P. L., Hough A. J., Jr. Cytokines in malignant lymphomas: review and prospective evaluation. Hum. Pathol. 1993; 24: 1040–1057
   PubMed Web of Science ®Google Scholar
• Banchereau J., Bazan F, Blanchard D., Briere F, Galizzi J. P., van Kooten C, Liu Y. J., Rousset F, Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Wakatsuki Y., Neurath M. F, Max E. E., Strober W. The B cell-specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 1994; 179: 1099–1108
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80–82
   PubMed Web of Science ®Google Scholar
• Gong J., Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 1994; 218: 314–319
   PubMed Web of Science ®Google Scholar
• Kaufmann Y., Levanon M., Davidsohn J., Ramot B. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity. J. Immunol. 1987; 139: 977–982
   PubMed Web of Science ®Google Scholar
• Csanaky G., Matutes E., Vass J. A., Morilla R., Catovsky D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 1997; 11: 408–415
   PubMed Web of Science ®Google Scholar
• Kimby E., Rincon J., Patarroyo M., Mellstedt H. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia. Leuk. Lym-phoma 1994; 13: 297–306
   PubMed Web of Science ®Google Scholar
• De Rossi G., Zarcone D., Mauro F., Cerruti G., Tenca C, Puccetti A., Mandelli F., Grossi C. E. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets. Blood 1993; 81: 2679–2687
   PubMed Web of Science ®Google Scholar
• Planken E. V., Dijkstra N. H., Willemze R., Kluin-Nelemans J. C. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the “CD40 system”. Leukemia 1996; 10: 488–493
   PubMed Web of Science ®Google Scholar
• Bischof F., Melms A. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes. Cell. Immunol. 1998; 187: 38–44
   PubMed Web of Science ®Google Scholar
• Panayiotidis P., Jones D., Ganeshaguru K., Foroni L., Hoffbrand A. V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 1996; 92: 97, -KB
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Tomhave E., Pratt L. F., Duffy S., Chen P. P., Carson D. A. Developmentally restricted immu-noglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 5913–5917
   PubMed Web of Science ®Google Scholar
• Shokri F., Mageed R. A., Richardson P., Jefferis R. Modulation and high frequency expression of autoan-tibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia (B-CLL). Scand. J. Immunol. 1993; 37: 673–679
   PubMed Web of Science ®Google Scholar
• Du M. Q., Diss T. C., Xu C. F., Wotherspoon A. C., Isaacson P. G., Pan L. X. Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br. J. Haematol. 1997; 96: 124–131
   PubMed Web of Science ®Google Scholar
• Burdin N., Van Kooten C, Galibert L., Abrams J. S., Wijdenes J., Banchereau J., Rousset F. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 1995; 154: 2533–2544
   PubMed Web of Science ®Google Scholar
• Pistoia V., Corcione A. Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes. Stem Cells 1995; 13: 487–500
   PubMed Web of Science ®Google Scholar
• Voorzanger N., Touitou R., Garcia E., Delecluse H. J., Rousset F, Joab I., Favrot M. C., Blay J. Y. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res. 1996; 56: 5499–5505
   PubMed Web of Science ®Google Scholar